Loading…
Back To Schedule
Wednesday, June 17 • 4:00pm - 5:00pm
#342 L: Drug Pricing in the United States: How and Why is it Different Than in the Rest of the World

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-20-671-L04-P; CME 1.00; IACET 1.00; RN 1.00

Drug Pricing in the United States continues to be a hotly debated subject. As candidates head into the US 2020 election, the topic will only garner more attention. This session will review the differences in worldwide drug pricing regulations and practices. The future landscape of drug pricing in the United States will be discussed, with a review of drug pricing proposals.

Learning Objectives

Compare US and non-US drug pricing regulations; Discuss the future landscape of US drug pricing;

Chair

Christopher Marrone, PharmD, RPh

Speaker

Global Perspective: Benchmarking Prescription Drug Price and Access Around the World
Scott Roberts, MBA

Pharmaceutical Pricing in the US Healthcare Market
Johann Odermann

Patient Affordability: Caught at the Intersection of Manufacturer and “System” Dynamics in Specialty Products
Aria Cohen, MBA


Speakers
avatar for Christopher Marrone

Christopher Marrone

Outcomes Liaison Advisor – National Accounts, Value, Evidence and Outcomes (VEO), Eli Lilly and Company, United States
Chris received his BS in Pharmacy from Rutgers University, and his PharmD from the University of Texas at Austin. He completed a Pharmacy Practice Residency at The University of Vermont Medical Center, and a Drug Information Specialty Residency with Lilly and Purdue University. Chris... Read More →
avatar for Aria Cohen

Aria Cohen

Senior Director, US Market Access, Apellis Pharmaceuticals
Aria Cohen is the Senior Director, Payer and Channel Marketing at Apellis Pharmaceuticals. Aria is focused on developing customer engagement strategies and tactics that maximize the patient access opportunity for Apellis' products with US payers. Prior to joining Apellis, Aria was... Read More →
avatar for Johann Odermann

Johann Odermann

Principal, JustSo Marketing
Johann provides strategic insight into the payer, managed markets, and policy worlds leveraging his 30 years of biopharmaceutical experience in large and small biopharmaceutical companies as well as agencies - including the past 20 years calling on payers or developing market access... Read More →
avatar for Scott Roberts

Scott Roberts

Managing Partner, Citrus Health Group
Co-founder of CiTRUS Health Group and head of CiTRUS Market Access, Scott guides biotechs and life sciences companies in global market access & pricing strategy, reimbursement, and value evidence. He is passionate about helping clients find innovative solutions in categories where... Read More →

Wednesday June 17, 2020 4:00pm - 5:00pm EDT
TBD Virtual Event Horsham, PA 19044
  12: Value-Access, Session